Astrazeneca | chemanager-online.com - Chemistry and Life Science

May. 22, 2020
News & Opinions
US Gives AstraZeneca $ 1 billion for Oxford Vaccine
The US Biomedical Advanced Research and Development Authority (BARDA) has added another illustrious European pharmaceutical industry player to the list of those whose resources it wants to tap to make a Covid-19 vaccine for the US. ...
May. 19, 2020
News & Opinions
AstraZeneca Targets 30 Million Vaccine Doses by September
Anglo-Swedish drugmaker AstraZeneca has announced it will make as many as 30 million initial doses of a potential Covid-19 vaccine available by September this year, assuming the success of late-stage trials expected to conclude by mid-year.
Mar. 27, 2020
News & Opinions
AstraZeneca Links with Silence Therapeutics
Anglo-Swedish drugmaker AstraZeneca has announced plans to collaborate with UK biotech Silence Therapeutics to discover, develop and commercialize small interfering RNA (siRNA) therapeutics for treating cardiovascular, renal, metabolic and ...
Dec. 06, 2019
Topics
Made in Switzerland – Exported Worldwide
The chemical, pharmaceutical and life sciences industries in Switzerland — organized in the Scienceindustries trade association — account for 45% of total exports with around 70,000 employees and are thus the undisputed ...
Nov. 14, 2019
News & Opinions
AstraZeneca Launches China R&D Initiatives
Major drugmaker AstraZeneca has announced plans to launch three initiatives in China to advance global R&D efforts. The plans include establishing global R&D and artificial intelligence (AI) innovation centers as well as creating a ...
Jun. 11, 2019
News & Opinions
North America Leads Pharma Sales Outlook
North America should continue to lead global pharmaceutical sales up to 2022, with $635 billion in revenue expected that year, drugmaker AstraZeneca said in a recently published outlook on the industry.
May. 08, 2019
News & Opinions
AstraZeneca and Transgene Link on Immunotherapy
Anglo-Swedish drugmaker AstraZeneca is to collaborate with French biotech Transgene, part of Institut Mérieux, to discover and develop immunotherapies for treating cancers and infectious diseases.
Apr. 03, 2019
News & Opinions
AstraZeneca in $6.9 Billion Rights Share Deal
In a move to accelerate the development of its oncology franchise, AstraZeneca has agreed a $6.9 billion deal with Japanese pharma major Daiichi Sankyo to share rights to a new breast cancer drug called DS-8201. ...
Dec. 14, 2018
News & Opinions
AVEO and AstraZeneca Link on Lung Cancer
US biopharma AVEO Oncology is collaborating with Anglo-Swedish drug major AstraZeneca on a combined treatment for liver cancer. ...
Nov. 14, 2018
News & Opinions
AstraZeneca Sells Synagis Rights to Sobi
Anglo-Swedish drugmaker AstraZeneca has sold US right for its Synagis infant respiratory drug to Swedish Orphan Biovitrum (Sobi) for an upfront sum of $1.5 billion. The payment consists of $1 billion in cash and $500 million in Sobi ...

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag